» Articles » PMID: 35681558

Added Value of Viscoelasticity for MRI-Based Prediction of Ki-67 Expression of Hepatocellular Carcinoma Using a Deep Learning Combined Radiomics (DLCR) Model

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Jun 10
PMID 35681558
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to explore the added value of viscoelasticity measured by magnetic resonance elastography (MRE) in the prediction of Ki-67 expression in hepatocellular carcinoma (HCC) using a deep learning combined radiomics (DLCR) model. This retrospective study included 108 histopathology-proven HCC patients (93 males; age, 59.6 ± 11.0 years) who underwent preoperative MRI and MR elastography. They were divided into training ( = 87; 61.0 ± 9.8 years) and testing ( = 21; 60.6 ± 10.1 years) cohorts. An independent validation cohort including 43 patients (60.1 ± 11.3 years) was included for testing. A DLCR model was proposed to predict the expression of Ki-67 with cMRI, including T2W, DW, and dynamic contrast enhancement (DCE) images as inputs. The images of the shear wave speed (-map) and phase angle (-map) derived from MRE were also fed into the DLCR model. The Ki-67 expression was classified into low and high groups with a threshold of 20%. Both and values were ranked within the top six features for Ki-67 prediction with random forest selection, which revealed the value of MRE-based viscosity for the assessment of tumor proliferation status in HCC. When comparing the six CNN models, Xception showed the best performance for classifying the Ki-67 expression, with an AUC of 0.80 ± 0.03 (CI: 0.79-0.81) and accuracy of 0.77 ± 0.04 (CI: 0.76-0.78) when cMRI were fed into the model. The model with all modalities (MRE, AFP, and cMRI) as inputs achieved the highest AUC of 0.90 ± 0.03 (CI: 0.89-0.91) in the validation cohort. The same finding was observed in the independent testing cohort, with an AUC of 0.83 ± 0.03 (CI: 0.82-0.84). The shear wave speed and phase angle improved the performance of the DLCR model significantly for Ki-67 prediction, suggesting that MRE-based and -maps can serve as important parameters to assess the tumor proliferation status in HCC.

Citing Articles

Imaging-Based Prediction of Ki-67 Expression in Hepatocellular Carcinoma: A Retrospective Study.

Cai C, Wang L, Tao L, Zhu H, Ren Y, Li D Cancer Med. 2025; 14(4):e70562.

PMID: 39964132 PMC: 11834164. DOI: 10.1002/cam4.70562.


Radiomics predicting immunohistochemical markers in primary hepatic carcinoma: Current status and challenges.

Yin Y, Zhang W, Chen Y, Zhang Y, Shen X Heliyon. 2024; 10(23):e40588.

PMID: 39660185 PMC: 11629216. DOI: 10.1016/j.heliyon.2024.e40588.


Artificial intelligence techniques in liver cancer.

Wang L, Fatemi M, Alizad A Front Oncol. 2024; 14:1415859.

PMID: 39290245 PMC: 11405163. DOI: 10.3389/fonc.2024.1415859.


MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy.

Kuang F, Gao Y, Zhou Q, Lu C, Lin Q, Al Mamun A J Hepatocell Carcinoma. 2024; 11:1445-1457.

PMID: 39050810 PMC: 11268741. DOI: 10.2147/JHC.S464916.


Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma.

Huang M, Zhang F, Li Z, Luo Y, Li J, Wang Z Front Oncol. 2024; 14:1367907.

PMID: 38665944 PMC: 11044697. DOI: 10.3389/fonc.2024.1367907.


References
1.
Zhao Y, Xiong X, Chen K, Tang W, Yang X, Shi Z . Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery. Front Oncol. 2021; 11:605234. PMC: 7947851. DOI: 10.3389/fonc.2021.605234. View

2.
Hu X, Yang Z, Liang H, Ding Y, Grimm R, Fu C . Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J Magn Reson Imaging. 2016; 46(2):383-392. DOI: 10.1002/jmri.25555. View

3.
Page G, Tardieu M, Gennisson J, Besret L, Garteiser P, Van Beers B . Tumor Solid Stress: Assessment with MR Elastography under Compression of Patient-Derived Hepatocellular Carcinomas and Cholangiocarcinomas Xenografted in Mice. Cancers (Basel). 2021; 13(8). PMC: 8071192. DOI: 10.3390/cancers13081891. View

4.
Aktas S, Karakayali H, Moray G, Ozdemir H, Haberal M . Effects of risk factors and Ki-67 on rates of recurrence on patients who have undergone liver transplant for hepatocellular carcinoma. Transplant Proc. 2011; 43(10):3807-12. DOI: 10.1016/j.transproceed.2011.09.067. View

5.
Fan Y, Yu Y, Wang X, Hu M, Hu C . Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma. BMC Med Imaging. 2021; 21(1):100. PMC: 8204550. DOI: 10.1186/s12880-021-00633-0. View